Cingulate CINGW
NASDAQ CINGW
$0.01 +0.00 (+4.29%)
As of: Sep 9, 2026 · 11:16 AM EDT

Cingulate (CINGW) Other financing activities (2021)

Cingulate's (CINGW) quarterly Other financing activities came in at -$2.0 in Q4 2021, down 100.0% quarter-over-quarter from $3.7 million in Q3 2021.

Analysis

Cingulate (CINGW) Other financing activities (2021) Analysis & Trends

Cingulate (CINGW) has reported Other financing activities for 1 consecutive years, with -$2.0 the latest figure, recorded in Q4 2021.

  • For the quarter ending Q4 2021, Other financing activities changed N/A year-over-year to -$2.0; the trailing twelve-month figure through Dec 2021 stood at $7.1 million (changed N/A YoY), and the FY2021 full-year result was $7.1 million, changed N/A from the prior year.
  • Other financing activities retreated to -$2.0 in Q4 2021 per CINGW's latest filing, from $3.7 million in the prior quarter.
  • Across five years, Other financing activities topped out at $3.7 million in Q3 2021 and bottomed at -$2.0 in Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 644.46 Bn 623.70 Bn 17.26 Bn
2 AbbVie 440.11 Bn 433.54 Bn 12.70 Bn
3 Merck 365.04 Bn 357.90 Bn 12.21 Bn
4 Novartis Ag 266.82 Bn 259.13 Bn 11.24 Bn
5 Pfizer 159.14 Bn 147.45 Bn 10.94 Bn
6 Sanofi 52.47 Bn 45.09 Bn 10.79 Bn
7 Revolution Medicines 44.26 Bn 44.26 Bn -
8 Incyte 25.32 Bn 20.79 Bn 1.57 Bn
9 United Therapeutics 21.46 Bn 18.80 Bn 683.80 Mn
10 Cingulate 100,214.03 100,214.03 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 -2.00
Sep 30, 2021 3.73 Mn
Jun 30, 2021 1.99 Mn
Mar 31, 2021 1.39 Mn